• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精间隔消融术治疗心力衰竭

Alcohol Septal Ablation to Reduce Heart Failure.

作者信息

McKay Joshua, Nagueh Sherif F

机构信息

Department of Cardiology, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, 6550 Fannin, Smith Tower 677, Houston, TX 77030, USA.

Department of Cardiology, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, 6550 Fannin, Smith Tower 677, Houston, TX 77030, USA.

出版信息

Interv Cardiol Clin. 2017 Jul;6(3):445-452. doi: 10.1016/j.iccl.2017.03.012. Epub 2017 Apr 21.

DOI:10.1016/j.iccl.2017.03.012
PMID:28600096
Abstract

Hypertrophic cardiomyopathy is a commonly encountered inheritable cardiac disorder with variable phenotypic expression. Although most patients will have no or mild symptoms, 10% will develop heart failure symptoms refractory to medical management. This article discusses the mechanisms through which hypertrophic cardiomyopathy induces heart failure and how alcohol septal ablation can reverse each of these mechanisms to lead to clinical improvement.

摘要

肥厚型心肌病是一种常见的遗传性心脏疾病,具有可变的表型表达。虽然大多数患者没有症状或仅有轻微症状,但10%的患者会出现药物治疗难以控制的心力衰竭症状。本文讨论了肥厚型心肌病诱发心力衰竭的机制,以及酒精室间隔消融如何逆转这些机制以实现临床改善。

相似文献

1
Alcohol Septal Ablation to Reduce Heart Failure.酒精间隔消融术治疗心力衰竭
Interv Cardiol Clin. 2017 Jul;6(3):445-452. doi: 10.1016/j.iccl.2017.03.012. Epub 2017 Apr 21.
2
Choice of Septal Reduction Therapies and Alcohol Septal Ablation.鼻中隔矫正治疗方法的选择与酒精性鼻中隔消融术
Cardiol Clin. 2019 Feb;37(1):83-93. doi: 10.1016/j.ccl.2018.08.009. Epub 2018 Oct 29.
3
Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of Balance.酒精室间隔消融术治疗梗阻性肥厚型心肌病:平衡之语。
J Am Coll Cardiol. 2017 Jul 25;70(4):489-494. doi: 10.1016/j.jacc.2017.06.011.
4
Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre.利用一项为期17年(平均10.8年)的纵向研究对肥厚型心肌病进行酒精间隔消融术。观察随访在单一医疗中心进行。
Cardiol J. 2017;24(2):125-130. doi: 10.5603/CJ.a2016.0089. Epub 2016 Oct 13.
5
Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy.三维对比超声心动图引导下的肥厚性梗阻性心肌病酒精室间隔消融术
Eur Heart J Cardiovasc Imaging. 2014 Feb;15(2):226. doi: 10.1093/ehjci/jet152. Epub 2013 Aug 29.
6
Low alcohol tolerance--a blessing for septal ablation.低酒精耐受性——间隔消融术的福音。
Catheter Cardiovasc Interv. 2014 Jul 1;84(1):108-9. doi: 10.1002/ccd.25537.
7
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.酒精室间隔消融术治疗肥厚型梗阻性心肌病。一项多中心北美注册研究。
J Am Coll Cardiol. 2011 Nov 22;58(22):2322-8. doi: 10.1016/j.jacc.2011.06.073.
8
Usefulness of Non-Anteroseptal Region Left Ventricular Hypertrophy Using Cardiac Magnetic Resonance to Predict Repeat Alcohol Septal Ablation for Refractory Obstructive Hypertrophic Cardiomyopathy.利用心脏磁共振成像评估非前间隔区域左心室肥厚对预测难治性梗阻性肥厚型心肌病酒精间隔消融术再治疗的价值
Am J Cardiol. 2017 Jul 1;120(1):124-130. doi: 10.1016/j.amjcard.2017.03.248. Epub 2017 Apr 12.
9
Survival after alcohol septal ablation versus conservative therapy in obstructive hypertrophic cardiomyopathy.梗阻性肥厚型心肌病经酒精间隔消融术与保守治疗后的生存率比较
Cardiol J. 2015;22(6):657-64. doi: 10.5603/CJ.a2015.0032. Epub 2015 Jun 23.
10
Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?外科室间隔心肌切除术或酒精室间隔消融术:哪种方法能为肥厚型梗阻性心肌病患者带来更好的治疗效果?
Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):951-961. doi: 10.1093/icvts/ivx001.

引用本文的文献

1
Alcohol Ablation of Cardiac Tissues Quantified and Evaluated Using CIELAB Euclidean Distances.使用 CIELAB 欧几里得距离对心脏组织进行量化和评估的酒精消融。
Tex Heart Inst J. 2020 Aug 1;47(4):265-270. doi: 10.14503/THIJ-19-7140.